Literature DB >> 18713750

Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.

Roman Szabo1, John P Hobson, Karin List, Alfredo Molinolo, Chen-Yong Lin, Thomas H Bugge.   

Abstract

Hepatocyte growth factor activator inhibitors (HAI)-1 and -2 are recently identified and closely related Kunitz-type transmembrane serine protease inhibitors. Whereas HAI-1 is well established as an inhibitor of the serine proteases matriptase and hepatocyte growth factor activator, the physiological targets of HAI-2 are unknown. Here we show that HAI-2 displays potent inhibitory activity toward matriptase, forms SDS-stable complexes with the serine protease, and blocks matriptase-dependent activation of its candidate physiological substrates proprostasin and cell surface-bound pro-urokinase plasminogen activator. To further explore the potential functional relationship between HAI-2 and matriptase, we generated a transgenic mouse strain with a promoterless beta-galactosidase marker gene inserted into the endogenous locus encoding HAI-2 protein and performed a global high resolution mapping of the expression of HAI-2, matriptase, and HAI-1 proteins in all adult tissues. This analysis showed striking co-localization of HAI-2 with matriptase and HAI-1 in epithelial cells of all major organ systems, thus strongly supporting a role of HAI-2 as a physiological regulator of matriptase activity, possibly acting in a redundant or partially redundant manner with HAI-1. Unlike HAI-1 and matriptase, however, HAI-2 expression was also detected in non-epithelial cells of brain and lymph nodes, suggesting that HAI-2 may also be involved in inhibition of serine proteases other than matriptase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713750      PMCID: PMC2570866          DOI: 10.1074/jbc.M801970200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.

Authors:  Kimitoshi Denda; Takeshi Shimomura; Toshiya Kawaguchi; Keiji Miyazawa; Naomi Kitamura
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

2.  Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor.

Authors:  T Shimomura; K Denda; A Kitamura; T Kawaguchi; M Kito; J Kondo; S Kagaya; L Qin; H Takata; K Miyazawa; N Kitamura
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

3.  Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains.

Authors:  C W Marlor; K A Delaria; G Davis; D K Muller; J M Greve; P P Tamburini
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

4.  Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis.

Authors:  Karin List; Christian C Haudenschild; Roman Szabo; WanJun Chen; Sharon M Wahl; William Swaim; Lars H Engelholm; Niels Behrendt; Thomas H Bugge
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

5.  Characterization of placental bikunin, a novel human serine protease inhibitor.

Authors:  K A Delaria; D K Muller; C W Marlor; J E Brown; R C Das; S O Roczniak; P P Tamburini
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

Review 6.  Human and mouse proteases: a comparative genomic approach.

Authors:  Xose S Puente; Luis M Sánchez; Christopher M Overall; Carlos López-Otín
Journal:  Nat Rev Genet       Date:  2003-07       Impact factor: 53.242

7.  Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma.

Authors:  Masamichi Yamauchi; Hiroaki Kataoka; Hiroshi Itoh; Tomoko Seguchi; Yoshiniro Hasui; Yukio Osada
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

8.  Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.

Authors:  Daniel Kirchhofer; Mark Peek; Wei Li; Jennifer Stamos; Charles Eigenbrot; Saloumeh Kadkhodayan; J Michael Elliott; Racquel T Corpuz; Robert A Lazarus; Paul Moran
Journal:  J Biol Chem       Date:  2003-06-18       Impact factor: 5.157

9.  The hepatocyte growth factor regulatory factors in human breast cancer.

Authors:  Christian Parr; Gareth Watkins; Robert E Mansel; Wen G Jiang
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

10.  Families of serine peptidases.

Authors:  N D Rawlings; A J Barrett
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

View more
  50 in total

Review 1.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

2.  Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and -2-mediated cell-surface localization.

Authors:  Andrew S Murray; Fausto A Varela; Thomas E Hyland; Andrew J Schoenbeck; Jordan M White; Lauren M Tanabe; Sokol V Todi; Karin List
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

Review 3.  Type II transmembrane serine proteases.

Authors:  Thomas H Bugge; Toni M Antalis; Qingyu Wu
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

4.  HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.

Authors:  C-H Tsai; C-H Teng; Y-T Tu; T-S Cheng; S-R Wu; C-J Ko; H-Y Shyu; S-W Lan; H-P Huang; S-F Tzeng; M D Johnson; C-Y Lin; P-W Hsiao; M-S Lee
Journal:  Oncogene       Date:  2013-10-14       Impact factor: 9.867

5.  Requirement of the activity of hepatocyte growth factor activator inhibitor type 1 for the extracellular appearance of a transmembrane serine protease matriptase in monkey kidney COS-1 cells.

Authors:  Yuka Miyake; Satoshi Tsuzuki; Makoto Yasumoto; Tohru Fushiki; Kuniyo Inouye
Journal:  Cytotechnology       Date:  2009-08-05       Impact factor: 2.058

6.  Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.

Authors:  Jehng-Kang Wang; Ming-Shyue Lee; I-Chu Tseng; Feng-Pai Chou; Ya-Wen Chen; Amy Fulton; Herng-Sheng Lee; Cheng-Jueng Chen; Michael D Johnson; Chen-Yong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2009-06-17       Impact factor: 4.249

7.  Mesotrypsin Has Evolved Four Unique Residues to Cleave Trypsin Inhibitors as Substrates.

Authors:  Alexandre P Alloy; Olumide Kayode; Ruiying Wang; Alexandra Hockla; Alexei S Soares; Evette S Radisky
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

8.  Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors.

Authors:  Trine Tamberg; Zebin Hong; Daphné De Schepper; Signe Skovbjerg; Daniel M Dupont; Lars Vitved; Christine R Schar; Karsten Skjoedt; Lotte K Vogel; Jan K Jensen
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

9.  Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2.

Authors:  Márcia Santos Pereira; Sónia Pires Celeiro; Ângela Margarida Costa; Filipe Pinto; Sergey Popov; Gisele Caravina de Almeida; Júlia Amorim; Manuel Melo Pires; Célia Pinheiro; José Manuel Lopes; Mrinalini Honavar; Paulo Costa; José Pimentel; Chris Jones; Rui Manuel Reis; Marta Viana-Pereira
Journal:  Cell Oncol (Dordr)       Date:  2019-11-07       Impact factor: 6.730

10.  The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Jeffrey Martin Schafer; Lotte K Vogel; Hiroaki Kataoka; Thomas H Bugge
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.